Drug B (not disclosed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Drug B (not disclosed), covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058) [Phase 3]